These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2548127)

  • 61. Mu type opioid receptors in rat periaqueductal gray-enriched P2 membrane are coupled to G-protein-mediated inhibition of adenylyl cyclase.
    Fedynyshyn JP; Lee NM
    FEBS Lett; 1989 Aug; 253(1-2):23-7. PubMed ID: 2547657
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Developmental pattern of opioid receptors in the striatum and hippocampus: evidence for a non-mature type of receptor in embryonic tissue.
    Barg J; Hatini V; Simantov R
    Prog Clin Biol Res; 1990; 328():141-4. PubMed ID: 2154769
    [No Abstract]   [Full Text] [Related]  

  • 63. Guanine nucleotide-binding protein-coupled and -uncoupled states of opioid receptors and their relevance to the determination of subtypes.
    Richardson A; Demoliou-Mason C; Barnard EA
    Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10198-202. PubMed ID: 1332034
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Opioid binding sites in the guinea pig and rat kidney: radioligand homogenate binding and autoradiography.
    Dissanayake VU; Hughes J; Hunter JC
    Mol Pharmacol; 1991 Jul; 40(1):93-100. PubMed ID: 1649966
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Disappearance of the mu-opiate receptor patches in the rat neostriatum following lesioning of the ipsilateral nigrostriatal dopamine pathway with 1-methyl-4-phenylpyridinium ion (MPP+): restoration by embryonic nigral dopamine grafts.
    Sirinathsinghji DJ; Dunnett SB
    Brain Res; 1989 Dec; 504(1):115-20. PubMed ID: 2557122
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Modulation by mu-opioid agonists of guanosine-5'-O-(3-[35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells.
    Traynor JR; Nahorski SR
    Mol Pharmacol; 1995 Apr; 47(4):848-54. PubMed ID: 7723747
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Mu/delta opioid site selectivity of some antidepressants.
    Codd EE; Walker RF
    NIDA Res Monogr; 1986; 75():351-4. PubMed ID: 2828984
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Differential inhibition of delta-opiate binding and low-Km GTPase stimulation by phospholipase A2 treatment.
    Lazar DF; Medzihradsky F
    Prog Clin Biol Res; 1990; 328():113-6. PubMed ID: 2154762
    [No Abstract]   [Full Text] [Related]  

  • 69. Agonist-induced functional desensitization of the mu-opioid receptor is mediated by loss of membrane receptors rather than uncoupling from G protein.
    Pak Y; Kouvelas A; Scheideler MA; Rasmussen J; O'Dowd BF; George SR
    Mol Pharmacol; 1996 Nov; 50(5):1214-22. PubMed ID: 8913353
    [TBL] [Abstract][Full Text] [Related]  

  • 70. GTPase and adenylate cyclase desensitize at different rates in NG108-15 cells.
    Vachon L; Costa T; Herz A
    Mol Pharmacol; 1987 Feb; 31(2):159-68. PubMed ID: 3027528
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Sodium regulation of agonist binding at opioid receptors. II. Effects of sodium replacement on opioid binding in guinea pig cortical membranes.
    Werling LL; Brown SR; Puttfarcken P; Cox BM
    Mol Pharmacol; 1986 Aug; 30(2):90-5. PubMed ID: 3016504
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Modulation of opioid receptor binding by cis and trans fatty acids.
    Remmers AE; Nordby GL; Medzihradsky F
    J Neurochem; 1990 Dec; 55(6):1993-2000. PubMed ID: 2172466
    [TBL] [Abstract][Full Text] [Related]  

  • 73. 14 beta-(Bromoacetamido)morphine irreversibly labels mu opioid receptors in rat brain membranes.
    Bidlack JM; Frey DK; Seyed-Mozaffari A; Archer S
    Biochemistry; 1989 May; 28(10):4333-9. PubMed ID: 2548575
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Molecular mechanisms of ligand binding to opioid receptors: selective inhibition by ethanol?
    Rapaka RS; Bhargava HN; Renugopalakrishnan V; Collins BJ
    NIDA Res Monogr; 1986; 75():355-8. PubMed ID: 2828985
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Nonselective coupling of the human mu-opioid receptor to multiple inhibitory G-protein isoforms.
    Gaibelet G; Meilhoc E; Riond J; Saves I; Exner T; Liaubet L; Nürnberg B; Masson JM; Emorine LJ
    Eur J Biochem; 1999 Apr; 261(2):517-23. PubMed ID: 10215864
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Transient expression of opioid receptors in defined regions of developing brain: are embryonic receptors selective?
    Barg J; Simantov R
    J Neurochem; 1991 Dec; 57(6):1978-84. PubMed ID: 1658229
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Evidence for coupling of the kappa opioid receptor to brain GTPase.
    Clark MJ; Levenson SD; Medzihradsky F
    Life Sci; 1986 Nov; 39(19):1721-7. PubMed ID: 3022093
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Expression of mu-, delta- and kappa-opioid receptors in baculovirus-infected insect cells.
    Obermeier H; Wehmeyer A; Schulz R
    Eur J Pharmacol; 1996 Dec; 318(1):161-6. PubMed ID: 9007528
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Pharmacological and anatomical evidence of selective mu, delta, and kappa opioid receptor binding in rat brain.
    Mansour A; Lewis ME; Khachaturian H; Akil H; Watson SJ
    Brain Res; 1986 Dec; 399(1):69-79. PubMed ID: 3026574
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Mu opioid receptor involvement in enkephalin activation of dopamine neurons in the ventral tegmental area.
    Latimer LG; Duffy P; Kalivas PW
    J Pharmacol Exp Ther; 1987 Apr; 241(1):328-37. PubMed ID: 3033208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.